Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Lifted by Two Sigma Investments LP

Two Sigma Investments LP boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 10,708.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 68,310 shares of the medical equipment provider's stock after acquiring an additional 67,678 shares during the period. Two Sigma Investments LP's holdings in Intuitive Surgical were worth $35,655,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Teza Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $1,013,000. Tidal Investments LLC raised its holdings in Intuitive Surgical by 207.1% in the 4th quarter. Tidal Investments LLC now owns 60,114 shares of the medical equipment provider's stock valued at $31,377,000 after acquiring an additional 40,539 shares during the last quarter. TrinityPoint Wealth LLC lifted its stake in shares of Intuitive Surgical by 22.6% during the 4th quarter. TrinityPoint Wealth LLC now owns 1,371 shares of the medical equipment provider's stock worth $716,000 after purchasing an additional 253 shares during the period. Stonebrook Private Inc. grew its position in shares of Intuitive Surgical by 7.7% in the fourth quarter. Stonebrook Private Inc. now owns 492 shares of the medical equipment provider's stock valued at $257,000 after purchasing an additional 35 shares during the period. Finally, Strategic Wealth Partners Ltd. purchased a new position in Intuitive Surgical during the fourth quarter worth about $301,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the sale, the chief financial officer now owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 32,700 shares of company stock valued at $16,865,621. Insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Citigroup reiterated a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Trading Down 0.6%

ISRG stock traded down $3.13 during trading on Friday, reaching $539.54. The stock had a trading volume of 1,138,538 shares, compared to its average volume of 1,644,578. The firm has a fifty day moving average price of $510.44 and a 200 day moving average price of $537.67. The company has a market capitalization of $193.38 billion, a P/E ratio of 84.17, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $396.15 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.